Primary sepsis in a university hospital in northern Sweden: A retrospective study

Acta Anaesthesiologica Scandinavica

Volumn 48, Issue 8, 2004, Pages 960-967

  Jacobson, Sofie ^a   Johansson, G ^a   Winso O ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

APACHE II; ICU length of stay; Mortality; Septic shock; Severe sepsis; TISS

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; STEROID;

ADULT; AGED; ARTICLE; BLOOD CULTURE; DISEASE SEVERITY; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; STEROID THERAPY; SWEDEN; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; URINE CULTURE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME;

EID: 4544286340     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-5172.2004.00458.x     Document Type: Article

References (19)

1. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Crit Care Med Chest 1992; 101: 1644-55.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-10.
3. Sands KE, Bates DW, Lanken PN et al. Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA 1997; 278: 234-40.
4. Edbrooke DL, Hibbert CL, Kingsley JM, Smith S, Bright NM, Quinn JM. The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit. Crit Care Med 1999; 27: 1760-7.
5. Myrén K, Nordling S, Persson U, Wennberg E. Costs, length of stay and mortality of patients with septicaemia severe sepsis in Sweden. Intensive Care Med 2002; 28: S67.
6. Nordling S, Persson U, Wennberg E. Outcome and health care costs associated with severe sepsis in Sweden. Intensive Care Med 2002; 28: S48.
7. Cullen DJ, Civetta JM, Briggs BA, Ferrara LC. Therapeutic intervention scoring system: a method for quantitative comparison of patient care. Crit Care Med 1974; 2: 57-60.
8. Pundziute-Lycka A, Dahlquist G, Nystrom L et al. The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-98. Diabetologia 2002; 45: 783-91.
9. Alberti C, Brun-Buisson C, Burchardi H et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28: 108-21.
10. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occuring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31: 2332-8.
11. Teres D, Rapoport J, Lemenshow S, Kim S, Akhras K. Effects of severity of illness on resource use by survivors and non-survivors of severe sepsis at intensive care unit admission. Crit Care Med 2002; 30: 2413-9.
12. Brun-Buisson C, Doyon F, Carlet J et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274: 968-74.
13. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
14. Bernard GR, Vincent JL, Laterre PF et al. CJ Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
15. Warren BL, Eid A, Singer P et al. KyberSept Trail Study Group. JAMA 2001; 286: 1869-78.
16. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-67.
17. Cook D, Rocker G, Marshall J et al. Level of Care Study Investigators and the Canadian Critical Care Trials Group. Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med 2003; 349: 1123-32.
18. Brun-Buisson C, Roudot-Thoraval F, Girou E, Grenier-Sennelier C, Durand-Zaleski I. The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis. Intensive Care Med 2003; 29: 1464-71.
19. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. Incidence and mortality of severe sepsis in surgical intensive care patients. the influence of patient gender on disease process and outcome. Intensive Care Med 2000; 26: 167-72.